Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS | ($7.0) | ($8.4) | ($5.9) | ($1.7) | ($1.3) | $9.3 | ($0.5) | ($2.6) | ($1.6) | ($1.6) | ($1.8) | ($2.0) | ($2.9) | ($2.9) | ($4.2) | ($3.0) | ($3.0) | ($3.9) | ($3.9) | ($5.3) |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Insmed Incorporated's last 12-month EPS is ($5.5), based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Insmed Incorporated's EPS growth was 5.3%. The average annual EPS growth rates for Insmed Incorporated have been 20.7% over the past three years, 8.8% over the past five years.
Over the last year, Insmed Incorporated's EPS growth was 5.3%, which is higher than industry growth of (0.1%). It indicates that Insmed Incorporated's EPS growth is Good.